Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04102891
Other study ID # S63023
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date February 2021
Est. completion date July 2021

Study information

Verified date September 2020
Source SmartWithFood
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

FLORA is a longitudinal intervention study with a randomized, parallel group design. Primary objective is to improve metabolic health through gut microbiota modulation by means of a retailer-driven personalized dietary intervention in a real-life setting. Four hundred Flemish pre-metabolic adults will be randomly divided into a control and treatment arm, each comprising 200 participants. The study period is divided into three phases: a four weeks characterization, a twelve weeks intervention, and a four weeks post-intervention phase. During the intervention phase, control participants' online Collect&Go shopping carts are adjusted in accordance with Flemish food-based dietary guidelines. Based on the same guidelines, participants are provided with personalized dietary advice considering their usual dietary pattern and level of food literacy. In the treatment arm, a similar intervention will be applied using guidelines based on a microbiota modulation diet (MMD). During intervention, all participants can contact a dietician helpline for additional advice on study-related dietary issues. Over the five months, saliva and fecal samples will be collected on a regular basis, with an intensive sampling period of seven consecutive days at the end of each study phase. A GP consult consisting of a short medical exam, blood withdrawal and medical questionnaire takes place each month. Further, online questionnaires on lifestyle, health and well-being will be sent by e-mail and each five days, participants complete a food diary through their smartphone. Fecal, saliva, blood samples and meta-data will be analysed to detect changes in metabolic health.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 400
Est. completion date July 2021
Est. primary completion date June 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria - Willingness to participate to the study and to sign the informed consent (Dutch) - Older than 18 years - Diagnosed with pre-metabolic syndrome (diagnosed with central obesity [waist circumference =80 cm for women and =94 cm for men] and one of the following criteria: elevated blood pressure [systolic =130 mm Hg, diastolic =85 mm Hg], raised triglycerides [>150 mg/dL], reduced HDL-cholesterol [<40 mg/dL in men, <50 mg/dL in women], or raised fasting plasma glucose [=100 mg/dL] - Residing in Belgium, no travels abroad planned longer than seven consecutive days during the five-months study period - Willingness to follow dietary guidelines during the three-months intervention period - Willingness to purchase bulk groceries primarily at Colruyt Group using the Collect&Go platform during the five-months study period - Access to a -20-18°C freezer Exclusion criteria - Chronic constipation (less than one defecation once a week) - Gastro-intestinal surgery within the past 3 months - Inflammatory bowel disease (IBD) or diverticulitis - Irritable bowel syndrome (IBS) - Any food allergy or food intolerance - Metabolic syndrome - Diabetes Mellitus Type 1 or Type 2 - Coeliac disease - Pregnant women or women planning a pregnancy during the study period - Lactating women - Subjects on a specific diet (e.g. vegetarian/vegan diet, gluten-free diet, lactose-free diet, high-protein diet) - Subjects being treated for hypertension or high cholesterol

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Microbiota modulation diet
The Collect&Go shopping carts of the 400 participants will be adapted by replacing food products by healthier alternative ones based on the Flemish food-based dietary guidelines and the microbiota modulation diet guidelines for the control and study arm respectively. Based on these guidelines, and the habitual dietary pattern and level of food literacy of the participant, personalized dietary advice will be provided. A dietitian helpline will be available for further nutritional issues as well.

Locations

Country Name City State
n/a

Sponsors (3)

Lead Sponsor Collaborator
SmartWithFood KU Leuven, Vlaams Instituut voor Biotechnologie

Outcome

Type Measure Description Time frame Safety issue
Primary Reduced waist circumference Participants' waist circumference (cm) decreases during the study period 5 months
Primary Reduced serum triglycerides Participants' serum triglyceride level (mg/dL) decreases during the study period (blood sample analysis) 5 months
Primary Reduced blood pressure Participants' blood pressure (mm Hg) decreases during the study period 5 months
Primary Elevated HDL-cholesterol Participants' HDL-cholesterol levels (mg/dL) increase during the study period (blood sample analysis) 5 months
Primary Reduced fasting plasma glucose Participants' fasting plasma glucose levels decrease during the study period (blood sample analysis) 5 months
See also
  Status Clinical Trial Phase
Recruiting NCT04635202 - Effect of Elliptical Training on Metabolic Homeostasis in Metabolic Syndrome N/A
Completed NCT04053686 - An Intervention to Reduce Prolonged Sitting in Police Staff N/A
Completed NCT05343858 - Pilot Study to Evaluate the Effect of Two Microalgae Consumption on Metabolic Syndrome N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Recruiting NCT05040958 - Carotid Atherosclerotic Plaque Load and Neck Circumference
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Active, not recruiting NCT02500147 - Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS) Phase 4
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Completed NCT03289897 - Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan N/A
Recruiting NCT05956886 - Sleep Chatbot Intervention for Emerging Black/African American Adults N/A
Completed NCT06057896 - Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
Active, not recruiting NCT03613740 - Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion Phase 2
Completed NCT04498455 - Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency Phase 4
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Completed NCT04117802 - Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome N/A
Completed NCT03697382 - Effect of Daily Steps on Fat Metabolism N/A
Completed NCT03241121 - Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome N/A
Completed NCT04509206 - Virtual Teaching Kitchen N/A
Completed NCT05124847 - TREating Pediatric Obesity N/A